Gene transfer-mediated expression of physiological numbers of the type II decoy receptor in a myelomonocytic cellular context dampens the response to interleukin-1

European Cytokine Network

Volumn 8, Issue 3, 1997, Pages 265-269

  Rol, Giselle Penton ^a   Polentarutti, Nadia ^a   Sironi, Marina ^a   Saccani, Simona ^a   Introna, Martino ^a   Mantovani, Alberto ^a,b,c  

^a Ist Ric Farmacologiche Mario Negri ^*  (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Interleukin 1; Monocytes; Receptors

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 8; RECOMBINANT INTERLEUKIN 1BETA;

ARTICLE; BONE MARROW CULTURE; CYTOPLASM; DELETION MUTANT; GENE TRANSFER; HUMAN; HUMAN CELL; IMMUNOGENETICS; PHYSIOLOGY; RECEPTOR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CELL LINE; HUMANS; INTERLEUKIN-1; INTERLEUKIN-8; MONOCYTES; RECEPTORS, INTERLEUKIN-1; RECEPTORS, INTERLEUKIN-1 TYPE II; SEQUENCE DELETION; TRANSFECTION;

EID: 9844227350     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Dinarello C A. 1989. Interleukin-1 and its biologically related cytokines. (Review) Adv. Immunol. 44: 153.
2. Dinarello C A. 1996. Biological basis for IL-1 in disease. (Review) Blood 87: 2095.
3. Colotta F, Dower S K, Sims J E, Mantovani A. 1994. The type II "decoy" receptor: novel regulatory pathway for interleukin-1. (Review) Immunol. Today 15: 562.
4. Arend W P. 1993. Interleukin-1 receptor antagonist. (Review) Adv. Immunol. 54: 167.
5. Sims J E, March C J, Cosman D, Widmer M B, Mac Donald H R, McMahan CJ, Grubin C E, Wignall J M, Jackson J L, Call S M, Friend D, Alpert A R, Gillis S, Urdal D L, Dower S K. 1988. cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily. Science 241: 585.
6. McMahan C J, Slack J L, Mosley B, Cosman D, Lupton S D, Brunton L L, Grubin C E, Wignall J M, Jenkins N A, Brannan C I, et al. 1991. A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. EMBO J. 10: 2821.
7. Chizzonite R, Truit T, Kilian P L, Stern A S, Nunes P, Parker K P, Kaffka K L, Chua A O, Lugg D K, Gubler U. 1989. Two high-affinity interleukin-1 receptors represent separate gene products. Proc. Natl. Acad. Sci. USA 86: 8029.
8. Korherr C, Hofmeister R, Wesche H, Falk W. 1997. A critical role tor interleukin-1 receptor accessory protein in interleukin-1 signaling. Eur. J. Immunol. 27: 262.
9. Weshe H, Korherr C, Kracht M, FaIk W, Resch K, Martin M U. 1997. The interleukin-1 receptor accessory protein (IL-1RAcP) is essential for IL-1-induced activation of interleukin-1 receptor-associated kinase (IRAK) and stress-activated protein kinases (SAP kinases). J. Biol. Chem. 272: 7727.
10. Greenfeder S A, Nunes P, Kwee L, Labow M, Chizzonite R, Ju G. 1995. Molecular cloning and characterization of a second subunit of the interleukin-1 receptor complex. J. Biol. Chem. 270: 13757.
11. Sims J E, Gayle M A, Slack J L, Alderson M R, Bird T A, Giri J G, Colotta F, Re F, Mantovani A, Shanebeck K, Grabstein K H, Dower S K. 1993. Interleukin-1 signaling occurs exclusively via the type I receptor. Proc. Natl. Acad. Sci. USA 90: 6155.
12. McKean D J, Podzorski R P, Bell M P, Nilson A E, Huntoon C J, Slack J, Dower S K, Sims J. 1993. Murine T helper cell-2 lymphocytes express type I and type II IL-1 receptors, but only the type I receptor mediates costimulatory activity. J. Immunol. 151: 3500.
13. Groves R W, Giri J, Sims J, Dower S K, Kupper T S. 1995. Inducible expression of type 2 IL-1 receptors by cultured human keratinocytes. Implication for IL-1-mediated processes in epidermis. J. Immunol. 154: 4065.
14. Malinowsky D, Chai Z, Bristulf J, Simoncsits A, Bartfai T. 1995. The type I interleukin-1 receptor mediates fever in the rat as shown by interleukin-1 receptor subtype selective ligands. Neurosci. Lett. 201: 33.
15. Colotta F, Re F, Muzio M, Bertini R, Polentarutti N, Sironi M, Giri J G, Dower S K, Sims J E, Mantovani A. 1993. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 261: 472.
16. Symons J A, Young P R, Duff G W. 1995. Soluble type II interleukin-1 (IL-1) receptor binds and blocks processing of IL-1 beta precursor and loses affinity for IL-1 receptor antagonist. Proc. Natl. Acad. Sci. USA 92: 1714.
17. Colotta F, Re F, Muzio M, Polentarutti N, Minty A, Caput D, Ferrara P, Mantovani A. 1994. Interleukin-13 induces expression and release of the interleukin-1 decoy receptor in human polymorphonuclear cells. J. Biol. Chem. 269: 12403.
18. Re F, Muzio M, De Rossi M, Polentarutti N, Giri J G, Mantovani A, Colotta F. 1994. The type II "receptor" as a decoy target for IL-1 in polymorphonuclear leukocytes: characterization of induction by dexamethasone and ligand binding properties of the released decoy receptor. J. Exp. Med. 179: 739.
19. Symons J A, Eastgate J A, Duff G W. 1990. A soluble binding protein specific for interleukin-1 beta is produced by activated mononuclear cells. Cytokine 2: 190.
20. Symons J A, Eastgate J A, Duff G W. 1991. Purification and characterization of a novel soluble receptor for interleukin-1. J. Exp. Med. 174: 1251.
21. Giri J G, Wells J, Dower S K, McCall C E, Guzman R N, Slack J, Bird T A, Shanebeck K, Grabstein K H, Sims J E, Alderson M R. 1994. Elevated levels of shed type II IL-1 receptor in sepsis. Potential role for type II receptor in regulation of IL-1 responses. J. Immunol. 153: 5802.
22. Pruitt J H, Welborn M B, Edwards P D, Harward T R, Seeger J W, Martin T D, Smith C, Kenney J A, Wesdorf R I, Meijer S, Cuesta M A, Abouhanze A, Copeland III E M, Giri J G, Sims J E, Moldawer L L, Oldenburg H S. 1996. Increased soluble interleukin-1 type II receptor concentrations in post-operative patients and in patients with sepsis syndrome. Blood 87: 3282.
23. Burger D, Chicheportiche R, Giri J G, Dayer J M. 1995. The inhibitory activity of human interleukin-1 receptor antagonist is enhanced by type II interleukin-1 soluble receptor and hindered by type I interleukin-1 soluble receptor. J. Clin. Invest. 96: 38.
24. Colotta F, Orlando S, Fadlon E J, Sozzani S, Matteucci C, Mantovani A. 1995. Chemoattractants induce rapid release of the interleukin-1 type II decoy receptor in human polymorphonuclear cells. J. Exp. Med. 181: 2181.
25. Colotta F, Saccani S, Giri J G, Dower S K, Sims J E, Introna M, Mantovani A. 1996. Regulated expression and release of the interleukin-1 decoy receptor in human mononuclear phagocytes. J. Immunol. 156: 2534.
26. Orlando S, Matteucci C, Fadlon E J, Buurman W A, Bardella M T, Colotta F, Introna M, Mantovani A. 1996. TNF-alfa, unlike other pro- and anti-inflammatory cytokines, induces rapid release of the IL-1 type II decoy receptor in human myelomonocytic cells. J. Immunol. 158: 3861.
27. Re F, Sironi M, Muzio M, Matteucci C, Introna M, Orlando S, Penton-Rol G, Dower S K, Sims J E, Colotta F, Mantovani A. 1996. Inhibition of interleukin-1 responsiveness by type II receptor gene transfer: a surface "receptor" with anti-interleukin-1 function. J. Exp. Med. 183: 1841.
28. Bossù P, Visconti U, Ruggiero P, Macchia G, Muda M, Bertini R, Bizzarri C, Colagrande A, Sabbatini V, Maurizi G, Del Grosso E, Tagliabue A, Boraschi D. 1995. Transfected type II interleukin-1 receptor impairs responsiveness of human keratinocytes to interleukin-1. Am. J. Pathol. 147: 1852.
29. Rauschmayr T, Groves R W, Kupper T S. 1997. Keratinocyte expression of the type 2 interleukin-1 receptor mediates local and specific inhibition of interleukin-1-mediated inflammation. Proc. Natl. Acad. Sci. USA 94: 5814.